Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124832493 | 12483249 | 3 | F | 20160826 | 20160621 | 20160902 | EXP | US-ROCHE-1776879 | ROCHE | 0.00 | F | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124832493 | 12483249 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | STARTED ABOUT 3 AND HALF YEARS AGO | U | 103792 | |||||||||
| 124832493 | 12483249 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | U | 103792 | |||||||||||
| 124832493 | 12483249 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | U | 103792 | |||||||||||
| 124832493 | 12483249 | 4 | SS | PERJETA | PERTUZUMAB | 1 | Unknown | STARTED ABOUT 3 AND HALF YEARS AGO | U | 125409 | SOLUTION FOR INFUSION | ||||||||
| 124832493 | 12483249 | 5 | SS | PERJETA | PERTUZUMAB | 1 | U | 125409 | |||||||||||
| 124832493 | 12483249 | 6 | SS | PERJETA | PERTUZUMAB | 1 | U | 125409 | |||||||||||
| 124832493 | 12483249 | 7 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Unknown | U | 125427 | ||||||||||
| 124832493 | 12483249 | 8 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | U | 125427 | |||||||||||
| 124832493 | 12483249 | 9 | SS | ABRAXANE | PACLITAXEL | 1 | Unknown | U | 0 | ||||||||||
| 124832493 | 12483249 | 10 | SS | ABRAXANE | PACLITAXEL | 1 | U | 0 | |||||||||||
| 124832493 | 12483249 | 11 | SS | ABRAXANE | PACLITAXEL | 1 | U | 0 | |||||||||||
| 124832493 | 12483249 | 12 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | Unknown | 0 | 100 | MG | QD | ||||||||
| 124832493 | 12483249 | 13 | C | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 124832493 | 12483249 | 14 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124832493 | 12483249 | 15 | C | CLARITIN (UNITED STATES) | 2 | 0 | |||||||||||||
| 124832493 | 12483249 | 16 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 124832493 | 12483249 | 17 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 124832493 | 12483249 | 18 | C | ALKA SELTZER ORIGINAL | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124832493 | 12483249 | 1 | HER-2 positive breast cancer |
| 124832493 | 12483249 | 2 | Metastases to skin |
| 124832493 | 12483249 | 3 | Breast cancer metastatic |
| 124832493 | 12483249 | 4 | HER-2 positive breast cancer |
| 124832493 | 12483249 | 5 | Metastases to skin |
| 124832493 | 12483249 | 6 | Breast cancer metastatic |
| 124832493 | 12483249 | 7 | Breast cancer |
| 124832493 | 12483249 | 8 | Metastases to skin |
| 124832493 | 12483249 | 9 | HER-2 positive breast cancer |
| 124832493 | 12483249 | 10 | Metastases to skin |
| 124832493 | 12483249 | 11 | Breast cancer metastatic |
| 124832493 | 12483249 | 12 | Hypertension |
| 124832493 | 12483249 | 15 | Hypersensitivity |
| 124832493 | 12483249 | 16 | Abdominal discomfort |
| 124832493 | 12483249 | 17 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124832493 | 12483249 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124832493 | 12483249 | Abdominal pain | |
| 124832493 | 12483249 | Blood glucose decreased | |
| 124832493 | 12483249 | Decreased appetite | |
| 124832493 | 12483249 | Dizziness | |
| 124832493 | 12483249 | Dyspnoea | |
| 124832493 | 12483249 | Headache | |
| 124832493 | 12483249 | Insomnia | |
| 124832493 | 12483249 | Metastases to skin | |
| 124832493 | 12483249 | Muscle spasms | |
| 124832493 | 12483249 | Nausea | |
| 124832493 | 12483249 | Pain | |
| 124832493 | 12483249 | Paraesthesia | |
| 124832493 | 12483249 | Pruritus | |
| 124832493 | 12483249 | Rash | |
| 124832493 | 12483249 | Rash erythematous | |
| 124832493 | 12483249 | Rash macular | |
| 124832493 | 12483249 | Sluggishness | |
| 124832493 | 12483249 | Swelling | |
| 124832493 | 12483249 | Unevaluable event | |
| 124832493 | 12483249 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124832493 | 12483249 | 7 | 20160720 | 0 | ||
| 124832493 | 12483249 | 9 | 201512 | 0 |